Cargando…
RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Editora Ltda.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604196/ http://dx.doi.org/10.1016/j.htct.2020.10.458 |
_version_ | 1783604091412283392 |
---|---|
author | Bombonatti, J.F. Carvalho, L.M. Loss, S.R. Langhi, M.M. Abdo, A.R.N. Bordin, J.O. Baiocchi, O.C.G. Filho, J.P.Z. Menezes, Y. Bachour, P. |
author_facet | Bombonatti, J.F. Carvalho, L.M. Loss, S.R. Langhi, M.M. Abdo, A.R.N. Bordin, J.O. Baiocchi, O.C.G. Filho, J.P.Z. Menezes, Y. Bachour, P. |
author_sort | Bombonatti, J.F. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7604196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier Editora Ltda. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76041962020-11-02 RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19 Bombonatti, J.F. Carvalho, L.M. Loss, S.R. Langhi, M.M. Abdo, A.R.N. Bordin, J.O. Baiocchi, O.C.G. Filho, J.P.Z. Menezes, Y. Bachour, P. Hematol Transfus Cell Ther 456 Published by Elsevier Editora Ltda. 2020-11 2020-10-31 /pmc/articles/PMC7604196/ http://dx.doi.org/10.1016/j.htct.2020.10.458 Text en Copyright © 2020 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | 456 Bombonatti, J.F. Carvalho, L.M. Loss, S.R. Langhi, M.M. Abdo, A.R.N. Bordin, J.O. Baiocchi, O.C.G. Filho, J.P.Z. Menezes, Y. Bachour, P. RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19 |
title | RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19 |
title_full | RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19 |
title_fullStr | RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19 |
title_full_unstemmed | RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19 |
title_short | RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19 |
title_sort | recaída atípica de mieloma múltiplo associada ao uso de tocilizumabe para covid -19 |
topic | 456 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604196/ http://dx.doi.org/10.1016/j.htct.2020.10.458 |
work_keys_str_mv | AT bombonattijf recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 AT carvalholm recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 AT losssr recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 AT langhimm recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 AT abdoarn recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 AT bordinjo recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 AT baiocchiocg recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 AT filhojpz recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 AT menezesy recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 AT bachourp recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19 |